The Association Between Polypharmacy and Hip Fracture in Osteoporotic Women: A Nested Case-Control Study in South Korea

Overview

Journal Clin Drug Investig

Date 2018 Oct 12

PMID 30306340

Citations 8

Authors

Hae-Young Park

Suji Kim

Hyun Soon Sohn

Jin-Won Kwon

Affiliations

Soon will be listed here.

Abstract

Background And Objective: Polypharmacy, regarded as an indicator of potentially inappropriate medications (PIMs), may lead to a higher risk of serious health consequences in elderly patients with osteoporosis. Thus, this study aimed to analyze the association between polypharmacy and hip fracture in patients with osteoporosis because only a limited number of studies have reported on this association, with inconsistent results to date.

Methods: In this nested case-control study using a population-based sample cohort, the target cases were female patients with hip fracture diagnosed with osteoporosis and aged ≥ 50 years. Polypharmacy (prescription of an average of five or more daily drugs), PIMs for hip fracture (such as benzodiazepines and glucocorticoids), Charlson Comorbidity Index (CCI) score, and other comorbidities were analyzed during the year preceding the diagnosis of hip fracture. Adjusted odds ratios (ORs) for hip fracture for the variables were also analyzed.

Results: The cases (n = 1003) showed higher exposure rates to polypharmacy, glucocorticoids, and benzodiazepines, and had more severe comorbidity statuses compared with the controls. The ORs for hip fracture adjusted for confounders increased with polypharmacy level, with persistent statistical significance in most analyses. The ORs (95% confidence intervals), with reference to the 0 to < 1 drug group, were 1.65 (1.31-2.08) and 2.11 (1.12-3.96) for the 5 to < 10 and 10 + drug groups, respectively, with adjustment for PIMs, and 1.34 (1.04-1.72) and 1.45 (0.76-2.80) for the 5 to < 10 and 10 + drug groups, respectively, with adjustment for PIMs and CCI score.

Conclusions: The results suggest that polypharmacy is associated with an increased risk of hip fracture after adjustment for confounders in patients with osteoporosis. These results highlight the importance of polypharmacy management in preventing hip fractures in patients with osteoporosis.

Citing Articles

Polypharmacy of Older Surgical Patients With Extremity Fractures.

Taniguchi T, Inagaki R, Michikawa T, Kawabata S, Yoshida M, Kawano Y Geriatr Orthop Surg Rehabil. 2024; 15:21514593241234431.

PMID: 38481828 PMC: 10935749. DOI: 10.1177/21514593241234431.

Hip Fracture Post-operative Mortality and Polypharmacy: A New Risk Predictor?.

Al-Khatib Y, Dasari K Cureus. 2023; 15(10):e47089.

PMID: 38021499 PMC: 10646685. DOI: 10.7759/cureus.47089.

The association of melatonin use and hip fracture: a matched cohort study.

Yang T, Wu J, Ding X, Zhou B, Xiong Y Osteoporos Int. 2023; 34(6):1127-1135.

PMID: 37036474 DOI: 10.1007/s00198-023-06740-8.

Medication management for patients with hip fracture at a regional hospital and associated primary care units in Norway: a descriptive study based on a survey of clinicians' experience and a review of patient records.

Henriksen B, Krogseth M, Nguyen C, Mathiesen L, Davies M, Andersen R BMJ Open. 2022; 12(11):e064868.

PMID: 36379642 PMC: 9668037. DOI: 10.1136/bmjopen-2022-064868.

Comprehensive Geriatric Assessment in the Emergency Department for Identifying Elderly Individuals at Risk of Hip Fracture.

Lin P, Huang H, Yen D J Acute Med. 2022; 12(3):113-121.

PMID: 36313609 PMC: 9561485. DOI: 10.6705/j.jacme.202209_12(3).0004.

References

Cadogan C, Ryan C, Hughes C . Appropriate Polypharmacy and Medicine Safety: When Many is not Too Many. Drug Saf. 2015; 39(2):109-16. PMC: 4735229. DOI: 10.1007/s40264-015-0378-5. View

Maher R, Hanlon J, Hajjar E . Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf. 2013; 13(1):57-65. PMC: 3864987. DOI: 10.1517/14740338.2013.827660. View

Kuijpers M, van Marum R, Egberts A, Jansen P . Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2007; 65(1):130-3. PMC: 2291281. DOI: 10.1111/j.1365-2125.2007.02961.x. View

Fried T, OLeary J, Towle V, Goldstein M, Trentalange M, Martin D . Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014; 62(12):2261-72. PMC: 4270076. DOI: 10.1111/jgs.13153. View

Dhalwani N, Fahami R, Sathanapally H, Seidu S, Davies M, Khunti K . Association between polypharmacy and falls in older adults: a longitudinal study from England. BMJ Open. 2017; 7(10):e016358. PMC: 5652576. DOI: 10.1136/bmjopen-2017-016358. View

Laflamme L, Monarrez-Espino J, Johnell K, Elling B, Moller J . Type, number or both? A population-based matched case-control study on the risk of fall injuries among older people and number of medications beyond fall-inducing drugs. PLoS One. 2015; 10(3):e0123390. PMC: 4376700. DOI: 10.1371/journal.pone.0123390. View

Kannus P, Niemi S, Palvanen M, Parkkari J . Continuously increasing number and incidence of fall-induced, fracture-associated, spinal cord injuries in elderly persons. Arch Intern Med. 2000; 160(14):2145-9. DOI: 10.1001/archinte.160.14.2145. View

Jacqmin-Gadda H, Fourrier A, Commenges D, Dartigues J . Risk factors for fractures in the elderly. Epidemiology. 1998; 9(4):417-23. View

Lai S, Liao K, Liao C, Muo C, Liu C, Sung F . Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study. Medicine (Baltimore). 2010; 89(5):295-299. DOI: 10.1097/MD.0b013e3181f15efc. View

10.

Pan H, Li C, Chen T, Su T, Wang K . Association of polypharmacy with fall-related fractures in older Taiwanese people: age- and gender-specific analyses. BMJ Open. 2014; 4(3):e004428. PMC: 3975737. DOI: 10.1136/bmjopen-2013-004428. View

11.

Mohd-Tahir N, Li S . Economic burden of osteoporosis-related hip fracture in Asia: a systematic review. Osteoporos Int. 2017; 28(7):2035-2044. DOI: 10.1007/s00198-017-3985-4. View

12.

Caeiro J, Bartra A, Mesa-Ramos M, Etxebarria I, Montejo J, Carpintero P . Burden of First Osteoporotic Hip Fracture in Spain: A Prospective, 12-Month, Observational Study. Calcif Tissue Int. 2016; 100(1):29-39. PMC: 5214753. DOI: 10.1007/s00223-016-0193-8. View

13.

Lee J, Lee Y, Moon S . Association between bone mineral density and clinical consequences: cross-sectional study of Korean postmenopausal women in an orthopaedic outpatient clinic. J Korean Med Sci. 2014; 29(8):1152-60. PMC: 4129210. DOI: 10.3346/jkms.2014.29.8.1152. View

14.

Lee J, Lee J, Park S, Shin S, Kim K . Cohort Profile: The National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea. Int J Epidemiol. 2016; 46(2):e15. DOI: 10.1093/ije/dyv319. View

15.

Park H, Park J, Sohn H, Kwon J . Association of Parkinsonism or Parkinson Disease with Polypharmacy in the Year Preceding Diagnosis: A Nested Case-Control Study in South Korea. Drug Saf. 2017; 40(11):1109-1118. DOI: 10.1007/s40264-017-0559-5. View

16.

Yu N, Chen P, Tsai H, Huang C, Chiu Y, Tsay W . Association of benzodiazepine and Z-drug use with the risk of hospitalisation for fall-related injuries among older people: a nationwide nested case-control study in Taiwan. BMC Geriatr. 2017; 17(1):140. PMC: 5504671. DOI: 10.1186/s12877-017-0530-4. View

17.

Buckley L, Guyatt G, Fink H, Cannon M, Grossman J, Hansen K . 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2017; 69(8):1521-1537. DOI: 10.1002/art.40137. View

18.

Rodriguez J, Monsalves-Alvarez M, Henriquez S, Llanos M, Troncoso R . Glucocorticoid resistance in chronic diseases. Steroids. 2016; 115:182-192. DOI: 10.1016/j.steroids.2016.09.010. View

19.

Kanis J, Johansson H, Oden A, Johnell O, De Laet C, Melton Iii L . A meta-analysis of prior corticosteroid use and fracture risk. J Bone Miner Res. 2004; 19(6):893-9. DOI: 10.1359/JBMR.040134. View

20.

Lai S, Lin C, Liao K . Use of Oral Corticosteroids and Risk of Hip Fracture in the Elderly in a Case-Control Study. Front Pharmacol. 2017; 8:625. PMC: 5600992. DOI: 10.3389/fphar.2017.00625. View